Novartis Ag

Glaxosmithkline Biologicals Sa

J. Craig Venter Institute

Novartis Vaccines & Diagnostics, Gmbh

Novartis Vaccines and Diagnostics Srl

Chiron S.r.l.

Chrion S.r.l.

Vincenzo Scarlato

Vega Masignani

Guido Grandi

Rino Rappuoli

Mariagrazia Pizza

Maria Scarselli

Cesira Galeotti

Marirosa Mora

Claire M Fraser

Herve Tettelin

Erin Hickey

Giulio Ratti

Jeremy Petersen

J Craig Venter

Guilio Ratti

Mariarosa Mora

Craig Venter

Maria Rosa Mora

Giulo Ratti

Jeremy D Peterson

Craig Ventor

Hervé Tettelin

The invention provides proteins from, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.

[object Object]

This invention provides, among other things, proteins, polypeptides, and fragments thereof, derived from the bacteriaB. Also provided are nucleic acids encoding for such proteins, polypeptides, and/or fragments, as well as nucleic acids complementary thereto e.g., antisense nucleic acids). Additionally, this invention provides antibodies which bind to the proteins, polypeptides, and/or fragments. This invention further provides expression vectors useful for making the proteins, polypeptides, and/or fragments, as well as host cells transformed with such vectors. This invention also provides compositions of the proteins, polypeptides, fragments, and/or nucleic acids, for use as vaccines, diagnostic reagents, immunogenic compositions, and the like. Methods of making the compositions and methods of treatment with the compositions are also provided. This invention also provides methods of detecting the proteins, polypeptides, fragments, and/or nucleic acids.

Neisserial antigenic peptides

This invention provides, among other things, proteins, polypeptides, and fragments thereof, derived from the bacteriaB. Also provided are nucleic acids encoding for such proteins, polypeptides, and/or fragments, as well as nucleic acids complementary thereto (e.g., antisense nucleic acids). Additionally, this invention provides antibodies which bind to the proteins, polypeptides, and/or fragments. This invention further provides expression vectors useful for making the proteins, polypeptides, and/or fragments, as well as host cells transformed with such vectors. This invention also provides compositions of the proteins, polypeptides, fragments, and/or nucleic acids, for use as vaccines, diagnostic reagents, immunogenic compositions, and the like. Methods of making the compositions and methods of treatment with the compositions are also provided. This invention also provides methods of detecting the proteins, polypeptides, fragments, and/or nucleic acids.

The invention provides proteins from(strains A & B) and from, including amino acid sequences, the corresponding nucleotide sequences, expression data, and serological data. The proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.

Neisserial antigens

The invention provides proteins from(strains A & B), including amino acid sequences, the corresponding nucleotide sequences, expression data, and serological data. The proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.

Meningococcal antigens

WO99/36544 discloses a large number of proteins from. The present invention relates to fragments of those proteins which comprise at least one antigenic determinant. Homologous sequences and proteins comprising these fragments are also disclosed.

Antigenic meningococcal peptides

The invention provides methods of obtaining immunogenic proteins from genomic sequences including, including the amino acid sequences and the corresponding nucleotide sequences, as well as the genomic sequence of. The proteins so obtained are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.

Growing community of inventors

Colle Val d'Elsa, Italy

Vincenzo Scarlato